| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/31/2000 | CA2362203A1 Isolation and characterization of a n. crassa silencing gene and uses thereof |
| 08/31/2000 | CA2361743A1 Genes associated with diseases of the colon |
| 08/31/2000 | CA2361396A1 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene |
| 08/31/2000 | CA2360847A1 Sequences for improving the efficiency of secretion of non-secreted proteins from mammalian and insect cells |
| 08/30/2000 | EP1031628A1 Process for the production of protease inhibitors |
| 08/30/2000 | EP1031627A1 Beta-carotene 15,15'-dioxygenase |
| 08/30/2000 | EP1031578A2 High purity albumin production by a multistep process |
| 08/30/2000 | EP1031037A1 Improvements in or relating to detection of molecules in samples |
| 08/30/2000 | EP1030928A1 Development of viruses resistant to inactivation by the human complement system |
| 08/30/2000 | EP1030926A2 Transgenic models of inflammatory disease |
| 08/30/2000 | EP1030925A1 The translation enhancer element of the human amyloid precursor protein gene |
| 08/30/2000 | EP1030923A2 Method for producing virus-like particles on the basis of polyoma viruses |
| 08/30/2000 | EP1030921A2 SOYBEAN HOMOLOG OF SEED-SPECIFIC TRANSCRIPTION ACTIVATOR FROM $i(PHASEOLUS VULGARIS) |
| 08/30/2000 | EP1030920A1 Methods for modulating nerve cell function |
| 08/30/2000 | EP1030919A2 Cdk2 protein and cdk2 protein complexes |
| 08/30/2000 | EP1030918A2 Slit polypeptide and method of modulation of robo with ligands |
| 08/30/2000 | EP1030917A1 Transcriptionally regulated g protein-coupled receptor |
| 08/30/2000 | EP1030916A2 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis |
| 08/30/2000 | EP1030915A1 A novel gene and uses therefor |
| 08/30/2000 | EP1030868A2 Design of coiled-coil dimer derived antagonists of 4-helix bundle cytokine specific receptors |
| 08/30/2000 | EP1030867A1 Mammalian milk growth factor |
| 08/30/2000 | EP1030866A2 Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids |
| 08/30/2000 | EP1030865A2 Th2 CELL DEPLETION; COMPOSITIONS; METHODS |
| 08/30/2000 | EP1030861A1 Modification of virus tropism and host range by viral genome shuffling |
| 08/30/2000 | EP1030859A1 Ras-binding protein (pre1) |
| 08/30/2000 | EP1030858A1 Method to diagnose and treat pathological conditions resulting from deficient ion transport |
| 08/30/2000 | EP1030819A1 Immunogenic conjugated polypeptide for treatment of herpes simplex virus |
| 08/30/2000 | EP1030685A2 Essential bacterial genes and their use |
| 08/30/2000 | EP1030683A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 08/30/2000 | EP1030679A1 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
| 08/30/2000 | EP1030658A1 Method of building and maintaining bone |
| 08/30/2000 | EP1006783A4 Shoot meristem specific promoter sequences |
| 08/30/2000 | EP0837692B1 Clostridium difficile toxins and toxoids as mucosal adjuvants |
| 08/30/2000 | EP0759937B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 08/30/2000 | EP0705274B1 Method and composition for treating thrombosis |
| 08/30/2000 | EP0671946B1 Immunoreactive peptides from epstein-barr virus |
| 08/30/2000 | EP0668772B1 Specific immune system modulation |
| 08/30/2000 | EP0642348B1 Antibiotic cryptdin peptides and methods of their use |
| 08/30/2000 | EP0631501B1 Glycosylation-mediated inhibition of factor x |
| 08/30/2000 | EP0584290B1 Endothelin antagonists |
| 08/30/2000 | EP0584287B1 Purification of müllerian inhibiting substance for treatment of certain tumors |
| 08/30/2000 | EP0573605B1 Preparation of factor ix |
| 08/30/2000 | EP0248819B2 Recombinant fibroblast growth factors |
| 08/30/2000 | CN1265159A Detection of wheat fungal pathogens using polymerase chain reaction |
| 08/30/2000 | CN1265151A Method for enhancement of naturally occurring cytoplasmic male sterility and for restoration of male fertility and uses thereof in hybrid crop prodn. |
| 08/30/2000 | CN1265148A Anticoagulant fusion protein anchored to cell membrane |
| 08/30/2000 | CN1265145A Hypersensitive response elicitor fragments and uses thereof |
| 08/30/2000 | CN1265144A Identification of human cell lines for prodn. of human proteins by endogenous gene activation |
| 08/30/2000 | CN1265143A Prodn. of erythropoietin by endogenous gene activation |
| 08/30/2000 | CN1264740A Human UMP-CMP kinase and its coding sequence, preparing process and application |
| 08/30/2000 | CN1264739A Human protein and its coding sequence, preparing process and application |
| 08/30/2000 | CN1264736A Recombination gluconokinase and its preparing process |
| 08/30/2000 | CN1264710A Modification and preparation of human interleukin 11 |
| 08/30/2000 | CN1264709A Human interleukin 11 derivative without amino acids at positions No.1-No.9 of N terminal |
| 08/30/2000 | CN1055932C Aglucone isoflavone enriched vegetable protein extract and isolate and process for producing same |
| 08/30/2000 | CN1055931C Aglucone isoflavone enriched vegetable protein concentrate and process for prouducing same |
| 08/29/2000 | USRE36844 Cellular attachment to trans-epithelial appliances |
| 08/29/2000 | US6111167 Nucleotide and amino acid sequences of polypeptide involved in cell development and apoptosis; for transgenic plants |
| 08/29/2000 | US6111166 Transgenic mice expressing human Fcα and β receptors |
| 08/29/2000 | US6111165 Production of human recombinant collagen in the milk of transgenic animals |
| 08/29/2000 | US6111093 Nucleotide sequence of cd antigen; for diagnosis and immunotherapy of related immune disorders |
| 08/29/2000 | US6111092 Nucleic acid molecules encoding DRT111 and uses thereof |
| 08/29/2000 | US6111091 Nucleotide sequence of ionotropic glutamate receptor; probes to identify and isolate related human receptor subunits; drug screening assays to identify agonists, antagonists, and modulators |
| 08/29/2000 | US6111090 Isolated or recombinant polynucleotide encodes a polypeptide expressed on activated t cells; treatment and diagnosis of abnormal immune responses such as t cell immune deficiency; antiinflammatory agents; immunosuppressants |
| 08/29/2000 | US6111089 Nucleic acid encoding a defined mouse amino acid sequence of a protein involved in embryo implantation; vaccine can be used as antifertility agent |
| 08/29/2000 | US6111088 Nucleotide sequence encoding a 52 kDa Ro/SSA autoantigen |
| 08/29/2000 | US6111087 Expression of a foamy virus envelope protein |
| 08/29/2000 | US6111081 Lactoferrin variants and uses thereof |
| 08/29/2000 | US6111078 Staphylococcus aureus rsbU-1 |
| 08/29/2000 | US6111076 Human G-protein coupled receptor (HIBCD07) |
| 08/29/2000 | US6111075 Protese-activated receptor PAR4 (ZCHEMR2) |
| 08/29/2000 | US6111074 Amino acid sequence of polypeptide from the uridine monophosphate kinase family; for screening bactericides and bacteriostats; for diagnosis and prophylaxis of infections |
| 08/29/2000 | US6111073 Amino acid and nucleotide sequences of polypeptides which are bound by and dephosphorylated by a family of protein tyrosine phosphatases; for inducing the polymerization of actin monomers in a eukaryotic cell |
| 08/29/2000 | US6111072 Rho target protein human mDia and gene encoding same |
| 08/29/2000 | US6111069 Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site |
| 08/29/2000 | US6111068 From the p-17 gag protein of human immunodeficiency virus; diagnosis; vaccines; viricides; prophylaxis and therapy for treating or suppressing acquired immune deficiency syndrome |
| 08/29/2000 | US6111066 Peptidic molecules which have been isotopically substituted with 13 C, 15 N and 2 H in the backbone but not in the sidechains |
| 08/29/2000 | US6111065 Inhibit neutrophil adhesion to p-selectin; antiinflammatory agents; anticoagulants; diagnostics |
| 08/29/2000 | US6110900 Nucleic acid ligands |
| 08/29/2000 | US6110899 LICC of Streptococcus pneumoniae |
| 08/29/2000 | US6110898 By administration of an antigen-encoding polynucleotide preparation to a mucosal inductor site in the mucosal tissue of the host; target protein antigen is administered through its expression by a recombinant gene expression vector |
| 08/29/2000 | US6110894 Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function |
| 08/29/2000 | US6110893 Fibroblast growth factor 11 |
| 08/29/2000 | US6110892 Peptides are derivatives of human parathyroid hormone (hpth) of given amino acid sequence which are cyclized in the form of a lactam between specified amino acid pairs; increased bioavailability |
| 08/29/2000 | US6110890 Inducing resistance to dutch elm disease (ded) in a susceptible elm tree by administering to the tree a glycoprotein elicitor of specified amino acid sequence derived from a ded causing fungus to cause a defense reaction |
| 08/29/2000 | US6110889 Administering hexapeptides of amino acid sequence arg-arg-trp-trp-cys-arg to inhibit alpha-chemokine binding to the tumor cell |
| 08/29/2000 | US6110747 Compounds and methods for modulating tissue permeability |
| 08/29/2000 | US6110746 Epitopes for early diagnosis of and antidiabetic agents for insulin-dependent diabetes; may be salts or functional derivatives such as chemical modification of amino acid side chains and/or carboxy and/or amino moieties |
| 08/29/2000 | US6110744 Diminishing viral gene expression by promoter replacement |
| 08/29/2000 | US6110743 Vector having at least two oncogenes, a pair of genetic elements which are recombination sites flanking the oncogenes, and another gene; for transformed cells which produce insulin and can be transplanted into human diabetic patients |
| 08/29/2000 | US6110740 Human vault RNA |
| 08/29/2000 | US6110738 Amino acid and nucleotide sequences of forkhead activin signal tranducer gene; protein binds to human smad2 and activates an activin response element; for screening test compounds which modulate transforming growth factor-beta |
| 08/29/2000 | US6110737 Nucleotide sequence; enhancing response of cells; determining regions involved in signal transduction; drug screening; for mutants; anticarcinogenic agents; wound healing agents; antiproliferative agents; prevention of atherosclerosis |
| 08/29/2000 | US6110734 Nucleotide sequences coding for polypeptides endowed with a larvicidal activity towards lepidoptera |
| 08/29/2000 | US6110708 Recombinant conglutinin and producing method thereof |
| 08/29/2000 | US6110707 Recombinant expression of proteins from secretory cell lines |
| 08/29/2000 | US6110706 Amino acid sequences; for increased immunogenicity |
| 08/29/2000 | US6110705 Recombinant Chlamydia trachomatis pgp3 fusion protein |
| 08/29/2000 | US6110704 3-ketoacyl-ACP-reductase (FabG) of Staphylococcus aureus |
| 08/29/2000 | US6110700 Nucleic acids that code a modulator of kinase activity; for the diagnosis tumorous condition; for development of models for the evaluation cancer in organ and tissues |